Direxion Daily S&P Biotech Bear 3X ETF
LABD
11 hedge funds and large institutions have $71.9M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
210.75% more ownership
Funds ownership: 43.17% → 253.92% (+211%)
149% more capital invested
Capital invested by funds: $28.8M → $71.9M (+$43M)
122% more call options, than puts
Call options by funds: $19.1M | Put options by funds: $8.62M
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
8% less funds holding
Funds holding: 12 → 11 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$76.3M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.82M |
| 3 |
VF
Virtu Financial
New York
|
+$4.78M |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$1.88M |
| 5 |
HF
HRT Financial
New York
|
+$1.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$1.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.08M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$551K |
| 4 |
Renaissance Technologies
New York
|
-$470K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$465K |
LABD Hedge Fund Activity: Q4 2020 in Review
11 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2020, worth a combined $71.9M — up 149% from $28.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LABD and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Boxer Capital, adding an estimated $76.3M. The largest seller was IMC Chicago, exiting entirely with an estimated $1.2M sold.
- 11 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2020, down from 12 in Q3 2020.
- Funds reported $71.9M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2020, up 149% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2020 and 6 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2020 was Boxer Capital, an estimated $76.3M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2020 was IMC Chicago, an estimated $1.2M sold.
Based on aggregated 13F filings for Q4 2020.